Skip to content
About Us
Pipeline
Publications
Careers
Investors
Careers
CLINICALTRIALS.GOV
The Crestone Study
All
Insights
Investors
Board of Directors
Leadership
Uncategorized
Our Partners
Scientific Advisory Committee
Publications
Newsroom
Filter by Quarter
2Q 2022
2Q 2024
1Q 2024
4Q 2023
3Q 2023
2Q 2023
1Q 2023
4Q 2022
3Q 2022
1Q 2022
4Q 2021
3Q 2021
2Q 2021
1Q 2021
4Q 2020
3Q 2020
January 18, 2024
Posters & Oral Presentations
A Phase 1 Study of EO-3021 in Adult Patients with Solid Tumors Likely to Express CLDN18.2
Presented at ASCO GI Cancers Symposium 2024
Read More
January 05, 2024
Press Releases
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Read More
November 02, 2023
Press Releases
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements
Read More
September 05, 2023
Press Releases
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Read More
August 16, 2023
Press Releases
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021
Read More
August 03, 2023
Press Releases
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
Read More
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
Load More
January 18, 2024
Posters & Oral Presentations
A Phase 1 Study of EO-3021 in Adult Patients with Solid Tumors Likely to Express CLDN18.2
Presented at ASCO GI Cancers Symposium 2024
Read More
January 05, 2024
Press Releases
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Read More
November 02, 2023
Press Releases
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements
Read More
September 05, 2023
Press Releases
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Read More
August 16, 2023
Press Releases
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021
Read More
August 03, 2023
Press Releases
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
Read More
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
Load More